Rhenman & Partners Asset Management AB
Position in IMCR — Immunocore Holdings plc
CIK 1599882
Stockholm, V7
Position in IMCR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,584,578
-$2,735,701 QoQ
Shares Held
85,724
-44.1% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rhenman & Partners Asset Management AB holds $297,378,771 across 37 Biotechnology names. IMCR ranks #32 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
48,100 | $37,163,984 | |
| 2 | INSM |
INSMED Inc
|
159,760 | $26,123,955 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
43,485 | $19,417,791 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
75,890 | $14,347,004 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
24,050 | $12,589,453 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
207,000 | $11,693,430 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
34,465 | $11,403,434 | |
| 8 | RPRX |
Royalty Pharma plc
|
233,000 | $11,177,010 |
All Filings in IMCR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,584,578 | 85,724 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,320,279 | 153,278 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,027,339 | 28,278 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $887,363 | 28,278 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $839,008 | 28,278 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,719,201 | 58,278 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,814,194 | 58,278 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,975,041 | 58,278 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,185,570 | 79,778 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,757,872 | 84,278 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,633,528 | 89,278 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,353,108 | 89,278 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,490,878 | 131,288 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,560,500 | 150,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,041,000 | 150,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,223,400 | 140,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,097,112 | 170,472 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,081,600 | 90,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,336,300 | 90,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,514,500 | 90,000 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||